New drug aims to boost infection defenses in rare blood disorder
Disease control
Recruiting now
This study tests an experimental drug called mavorixafor in people with chronic neutropenia, a condition where the body doesn't make enough neutrophils (a type of white blood cell), leading to frequent or serious infections. The goal is to see if the drug can safely raise neutrop…
Phase: PHASE3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control
Last updated May 04, 2026 16:30 UTC